A prospective observational study to establish an optimal Adalimumab serum trough level (ATL) range in rheumatoid arthritis patients with good clinical response
Latest Information Update: 02 Jul 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics; Therapeutic Use
- 02 Jul 2017 New trial record
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism